Stock report · Delisted · Nasdaq
NAYA Biosciences, Inc (NAYA)
2.20USD Delisted Final close · Apr 25, 2025
NAYA no longer trades. NAYA Biosciences was delisted from the Nasdaq in April 2025.
All prices on this page are historical. The last trade was on April 25, 2025, at $2.20.
NAYA stock price history
Final trading statistics
- Final close
- $2.20
- Final trading day
- Apr 25, 2025
- Market cap at delisting
- $2.48M
- Shares outstanding
- 4.48M
- Final 52-week range
- $0.19 – $2.75
- Avg. volume (final 3 mo.)
- 59,000
- All-time high
- $53760.00 · Nov 2008
- All-time low
- $1.72 · Apr 2025
- Return since IPO
- -99.9%
- Beta
- —
- Book value / share
- −$3.91
- Price / book
- -0.56
About NAYA Biosciences, Inc
INVO Fertility, known as NAYA Biosciences until April 2025, was a life science portfolio company developing clinical-stage treatments for fertility, cancer and autoimmune diseases. It had two divisions: NAYA Women's Health and NAYA Therapeutics.
Its lead programs were NY-303, a GPC3-targeted FLEX-NK bispecific antibody in Phase I/II trials for liver cancer and other solid and pediatric tumors, and NY-338, a CD38-targeted FLEX-NK bispecific antibody for multiple myeloma and autoimmune disease. It also sold INVOcell, a medical device that lets fertilization and early embryo growth happen inside the woman's body.
The company was founded in 2007 and based in Sarasota, Florida. Its shares were delisted from the Nasdaq in April 2025, with the final trade on April 25, 2025 at $2.20.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Sarasota, FL
- Employees
- —
- IPO date
- May 21, 2012
- Delisted
- April 25, 2025
- SEC CIK
- 1417926
NAYA Biosciences financials before the delisting
The last 5 fiscal years NAYA Biosciences reported as a public company, fiscal year ending December.
NAYA revenue and net income
NAYA earnings per share
NAYA annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $6.53M | −$9.1M | — |
| FY2023 | $3.02M | −$8.0M | — |
| FY2022 | $822.2K | −$10.9M | — |
| FY2021 | $4.16M | −$6.7M | — |
| FY2020 | $1.04M | −$8.3M | — |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
NAYA Biosciences stock FAQ
What happened to NAYA Biosciences stock?
NAYA Biosciences was delisted from the Nasdaq in April 2025. The final close was $2.20 on April 25, 2025.
Can I still buy NAYA stock?
No. NAYA is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on April 25, 2025.
What was the last price of NAYA?
NAYA last closed at $2.20 on April 25, 2025, which valued the company at about $2.48M.
How did NAYA Biosciences do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, NAYA Biosciences reported revenue of $6.53M and net income of −$9.1M.
When did NAYA Biosciences go public?
NAYA Biosciences shares started trading on May 21, 2012.
NAYA no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.